LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares +15.4% ·
flujo de acciones -17.1% ·
nuevas posiciones netas +13.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +5 | 56.58M | $15.83B | +9 | −3 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | — | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | — |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | — | 5.93M | $1.21B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 3.83M | +3.3% | $890.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 2.07M | +3.2% | $479.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.07M | +3.2% | $479.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Norges Bank ✦ (pasivo) | 982.97K | -6.0% | $228.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 265.25K | +0.7% | $61.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 265.25K | +0.7% | $61.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 265.25K | +0.7% | $61.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 265.25K | +0.7% | $61.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 265.25K | +0.7% | $61.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 203.93K | +73.1% | $47.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 203.93K | +73.1% | $47.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 163.80K | +8.1% | $37.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 163.80K | +8.1% | $37.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 163.80K | +8.1% | $37.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 163.80K | +8.1% | $37.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 163.80K | +8.1% | $37.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 109.80K | Nuevo | $25.55M | 0.1% | New | 1 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 70.10K | +64.4% | $16.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 69.24K | Nuevo | $16.12M | 0.0% | New | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 69.24K | Nuevo | $16.12M | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 67.44K | -90.4% | $15.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 62.82K | +145.0% | $14.62M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 31.38K | -43.7% | $7.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 18.05K | -50.5% | $4.20M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 2.31K | -99.8% | $537,164 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 1.83K | -10.1% | $425,566 | 0.0% | ▼ Trim | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $25.55M | 0.1% |
| Marshall Wace | $16.12M | 0.0% |
| Marshall Wace | $16.12M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,014 tenedores, 76.41M acciones, $19.36B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 3.00K acc. · $954,060
Officer, Director · 4.67K acc. · $1.50M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología